124 related articles for article (PubMed ID: 21720659)
1. Medication choice and associated health care outcomes and costs for patients with acne and acne-related conditions in the United States.
Patel P; Lin HC; Feldman SR; Fleischer AB; Nahata MC; Balkrishnan R
J Drugs Dermatol; 2011 Jul; 10(7):766-71. PubMed ID: 21720659
[TBL] [Abstract][Full Text] [Related]
2. Predictors of healthcare outcomes and costs related to medication use in patients with acne in the United States.
Balkrishnan R; Kulkarni AS; Cayce K; Feldman SR
Cutis; 2006 Apr; 77(4):251-5. PubMed ID: 16706243
[TBL] [Abstract][Full Text] [Related]
3. Medication use and associated health care outcomes and costs for patients with psoriasis in the United States.
Lin HC; Lucas PT; Feldman SR; Balkrishnan R
J Dermatolog Treat; 2012 Jun; 23(3):196-202. PubMed ID: 21254887
[TBL] [Abstract][Full Text] [Related]
4. Medication adherence, healthcare costs and utilization associated with acne drugs in Medicaid enrollees with acne vulgaris.
Tan X; Al-Dabagh A; Davis SA; Lin HC; Balkrishnan R; Chang J; Feldman SR
Am J Clin Dermatol; 2013 Jun; 14(3):243-51. PubMed ID: 23572294
[TBL] [Abstract][Full Text] [Related]
5. The cost-effectiveness of isotretinoin in the treatment of acne. Part 2. A chronic medication plan profiling study.
Wessels F; Anderson AN; Kropman K
S Afr Med J; 1999 Jul; 89(7 Pt 2):785-90. PubMed ID: 10470318
[TBL] [Abstract][Full Text] [Related]
6. Medication-related factors affecting health care outcomes and costs for patients with psoriasis in the United States.
Kulkarni AS; Balkrishnan R; Richmond D; Pearce DJ; Feldman SR
J Am Acad Dermatol; 2005 Jan; 52(1):27-31. PubMed ID: 15627077
[TBL] [Abstract][Full Text] [Related]
7. Use of drospirenone/ethinyl estradiol (DRSP/EE) among women with acne reduces acne treatment-related resources.
Joish VN; Boklage S; Lynen R; Schmidt A; Lin J
J Med Econ; 2011; 14(6):681-9. PubMed ID: 21892859
[TBL] [Abstract][Full Text] [Related]
8. The cost-effectiveness of isotretinoin in the treatment of acne. Part 3. A cost-minimisation pharmaco-economic model.
Wessels F; Anderson AN; Kropman K
S Afr Med J; 1999 Jul; 89(7 Pt 2):791-4. PubMed ID: 10470319
[TBL] [Abstract][Full Text] [Related]
9. [Acne. Introduction: which methods for what new treatments?].
Daniel F
Ann Dermatol Venereol; 2001 Apr; 128 Supp 1():S5-6. PubMed ID: 11450402
[No Abstract] [Full Text] [Related]
10. Prescribing patterns for topical retinoids: analyses of 15 years of data from the national ambulatory medical care survey.
Balkrishnan R; Bhosle MJ; Camacho F; Fleischer AB; Feldman SR
J Dermatolog Treat; 2010 May; 21(3):193-200. PubMed ID: 19895328
[TBL] [Abstract][Full Text] [Related]
11. Trends in prescription of acne medication in the US: shift from antibiotic to non-antibiotic treatment.
Thevarajah S; Balkrishnan R; Camacho FT; Feldman SR; Fleischer AB
J Dermatolog Treat; 2005; 16(4):224-8. PubMed ID: 16249143
[TBL] [Abstract][Full Text] [Related]
12. Patient characteristics and prescription fill patterns for allergic rhinitis medications, with a focus on montelukast, in a commercially insured population.
Bollinger ME; Diette GB; Chang CL; Stephenson JJ; Sajjan SG; Fan T; Allen-Ramey FC
Clin Ther; 2010 Jun; 32(6):1093-102. PubMed ID: 20637964
[TBL] [Abstract][Full Text] [Related]
13. Tretinoin gel microspheres 0.04% versus 0.1% in adolescents and adults with mild to moderate acne vulgaris: a 12-week, multicenter, randomized, double-blind, parallel-group, phase IV trial.
Berger R; Rizer R; Barba A; Wilson D; Stewart D; Grossman R; Nighland M; Weiss J
Clin Ther; 2007 Jun; 29(6):1086-97. PubMed ID: 17692723
[TBL] [Abstract][Full Text] [Related]
14. Costs associated with attempted suicide among individuals with bipolar disorder.
Stensland MD; Zhu B; Ascher-Svanum H; Ball DE
J Ment Health Policy Econ; 2010 Jun; 13(2):87-92. PubMed ID: 20919595
[TBL] [Abstract][Full Text] [Related]
15. Prescribing patterns for topical retinoids within NAMCS data.
Balkrishnan R; Sansbury JC; Shenolikar RA; Fleischer AB; Feldman SR
J Drugs Dermatol; 2005; 4(2):172-9. PubMed ID: 15776774
[TBL] [Abstract][Full Text] [Related]
16. Medication and medical service utilization for acne 1995-1998.
Stern RS
J Am Acad Dermatol; 2000 Dec; 43(6):1042-8. PubMed ID: 11100021
[TBL] [Abstract][Full Text] [Related]
17. Phase 4 study to assess tretinoin pump for the treatment of facial acne.
Eichenfield LF; Nighland M; Rossi AB; Cook-Bolden F; Grimes P; Fried R; Levy S;
J Drugs Dermatol; 2008 Dec; 7(12):1129-36. PubMed ID: 19137766
[TBL] [Abstract][Full Text] [Related]
18. Differences in acne treatment prescribing patterns of pediatricians and dermatologists: an analysis of nationally representative data.
Yentzer BA; Irby CE; Fleischer AB; Feldman SR
Pediatr Dermatol; 2008; 25(6):635-9. PubMed ID: 19067874
[TBL] [Abstract][Full Text] [Related]
19. Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.
Pawaskar MD; Camacho FT; Anderson RT; Cobden D; Joshi AV; Balkrishnan R
Clin Ther; 2007 Jun; 29(6 Pt 1):1294-305. PubMed ID: 18036391
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacoeconomy in acne--evaluation of benefit and economics].
Radtke MA; Schäfer I; Augustin M
J Dtsch Dermatol Ges; 2010 Mar; 8 Suppl 1():S105-14. PubMed ID: 20482687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
